1de Vroege R,van Oeveren W,van Klarenbosch J,et al.The impact of heparin-coated cardiopulmonary bypass circuits on pulmonary function and the release of inflammatory mediators[J].Anesth Analg,2004,98(6):1586-1594.
2Heijmans JH,Liem KS,Damoiseaux GM,et al.Pulmonary function and inflammatory markers in patients undergoing coronary revascularisation with or without cardiopulmonary bypass[J].Anaesthesia,2007,62(12):1233-1240.
3Muth H,Kreis I,Zimmermann R,et al.Differential gene expression in activated monocyte-derived macrophages following binding of factor VIIa to tissue factor[J].Thromb Haemost,2005,94(5):1028-1034.
4Mossinger H,Dietrich W,Braun SL,et al.High-dose aprotinin reduces activation of hemostasis,allogeneic blood requirement,and duration of postoperative ventilation in pediatric cardiac surgery[J].Ann Thorac Surg,2003,75 (2):430-437.
5Dodd-o JM,Welsh LE,Salazar JD,et al.Effect of bronchial artery blood flow on cardiopulmonary bypass-induced lung injury[J].Am J Physiol Heart Circ Physiol,2004,286(2):H693-700.
6Pugia MJ,Lott JA.Pathophysiology and diagnostic value of urinary trypsin inhibitors[J].Clin Chem Lab Med,2005,43(1):1-16.
7Bingyang J,Jinping L,Mingzheng L,et al.Effects of urinary protease inhibitor on inflammatory response during on-pump coronary revascularisation.Effect of ulinastatin on inflammatory response[J].J Cardiovasc Surg(Torino),2007,48(4):497-503.
8Deblier I,Sadowska AM,Janssens A,et al.Markers of inflammation and oxidative stress in patients undergoing CABG with CPB with and without ventilation of the lungs:a pilot study[J].Interact Cardiovasc Thorac Surg,2006,5(4):387-391.
